Telomeres and telomerase in the radiation response: Implications for instability, reprograming, and carcinogenesis

Frontiers in Oncology

Volumn 5, Issue NOV, 2015, Pages

  Sishc, Brock J ^a,b   Nelson, Christopher B ^b   McKenna, Miles J ^b   Battaglia, Christine L R ^b   Herndon, Andrea ^b   Idate, Rupa ^b   Liber, Howard L ^b   Bailey, Susan M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Carcinogenesis; Cellular reprograming; Instability; Ionizing radiation; Stem cells; Telomerase; Telomeres

Indexed keywords

BETA GALACTOSIDASE; TELOMERASE;

ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IONIZING RADIATION; LINEAR ENERGY TRANSFER; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TELOMERE; WESTERN BLOTTING;

EID: 84949743404     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00257     Document Type: Article

References (100)

1. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA-sequence; (Ttaggg)N; present at the telomeres of human-chromosomes. Proc Natl Acad Sci U S A (1988) 85:6622-6. doi:10.1073/pnas.85.18.6622.
2. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 19:2100-10. doi:10.1101/gad.1346005.
3. Bianchi A, Smith S, Chong L, Elias P, de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J (1997) 16:1785-94. doi:10.1093/emboj/16.7.1785.
4. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet (1997) 17:231-5. doi:10.1038/ng1097-231.
5. Baumann P, Cech TR. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science (2001) 292:1171-5. doi:10.1126/science.1060036.
6. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, et al. Mammalian telomeres end in a large duplex loop. Cell (1999) 97:503-14. doi:10.1016/S0092-8674(00)80760-6.
7. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR (1971) 201:1496-9.
8. Watson JD. Origin of concatameric T4 DNA. Nature (1972) 239:197-201.
9. Hayflick CB. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res (1965) 37:614-36. doi:10.1016/0014-4827(65)90211-9.
10. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature (1990) 345:458-60. doi:10.1038/345458a0.
11. DePinho RA. The age of cancer. Nature (2000) 408:248-54. doi:10.1038/35041694.
12. Murnane JP, Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays (2004) 26:1164-74. doi:10.1002/bies.20125.
13. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ (2014) 349:g4227. doi:10.1136/bmj.g4227.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 266:2011-5. doi:10.1126/science.7605428.
15. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med (1997) 3:1271-4. doi:10.1038/nm1197-1271.
16. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase-activity in tetrahymena extracts. Cell (1985) 43:405-13. doi:10.1016/0092-8674(85)90170-9.
17. Greider CW, Blackburn EH. A telomeric sequence in the RNA of tetrahymena telomerase required for telomere repeat synthesis. Nature (1989) 337:331-7. doi:10.1038/337331a0.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature (2001) 414:105-11. doi:10.1038/35102167.
19. Low KC, Tergaonkar V. Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci (2013) 38:426-34. doi:10.1016/j.tibs.2013.07.001.
20. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov (2009) 8:806-23. doi:10.1038/nrd2137.
21. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 100:3983-8. doi:10.1073/pnas.0530291100.
22. Joshua B, Kaplan MJ, Doweck I, Pai R, Weissman IL, Prince ME, et al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck (2012) 34:42-9. doi:10.1002/hed.21699.
23. Yang G, Quan Y, Wang W, Fu Q, Wu J, Mei T, et al. Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br J Cancer (2012) 106:1512-9. doi:10.1038/bjc.2012.126.
24. O'Flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, et al. The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy. J Thorac Oncol (2012) 7:1880-90. doi:10.1097/JTO.0b013e31826bfbc6.
25. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol (2007) 18:460-6. doi:10.1016/j.copbio.2007.10.007.
26. Chan KS, Volkmer JP, Weissman I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol (2010) 20:393-7. doi:10.1097/MOU.0b013e32833cc9df.
27. Du Z, Qin R, Wei C, Wang M, Shi C, Tian R, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Dig Dis Sci (2011) 56:741-50. doi:10.1007/s10620-010-1340-0.
28. Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M. Senescence evasion by MCF-7 human breast tumor-initiating cells. Breast Cancer Res (2010) 12:R31. doi:10.1186/bcr2583.
29. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells (2012) 30:833-44. doi:10.1002/stem.1058.
30. Murillo-Sauca O, Chung MK, Shin JH, Karamboulas C, Kwok S, Jung YH, et al. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget (2014) 5:6854-66. doi:10.18632/oncotarget.2269.
31. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res (2010) 12:R13. doi:10.1186/bcr2479.
32. Silvestre DC, Pineda JR, Hoffschir F, Studler JM, Mouthon MA, Pflumio F, et al. Alternative lengthening of telomeres in human glioma stem cells. Stem Cells (2011) 29:440-51. doi:10.1002/stem.600.
33. Tang J, Fernandez-Garcia I, Vijayakumar S, Martinez-Ruiz H, Illa-Bochaca I, Nguyen DH, et al. Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors. Stem Cells (2013) 32(3):649-61. doi:10.1002/stem.1533.
34. Butof R, Dubrovska A, Baumann M. Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol (2013) 108:388-96. doi:10.1016/j.radonc.2013.06.002.
35. Ogawa K, Yoshioka Y, Isohashi F, Seo Y, Yoshida K, Yamazaki H. Radiotherapy targeting cancer stem cells: current views and future perspectives. Anticancer Res (2013) 33(3):747-54.
36. Hoffmeyer K, Raggioli A, RudloffS, Anton R, Hierholzer A, Del Valle I, et al. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science (2012) 336:1549-54. doi:10.1126/science.1218370.
37. Greider CW. Molecular biology. Wnt regulates TERT-putting the horse before the cart. Science (2012) 336:1519-20. doi:10.1126/science.1223785.
38. Martinez P, Blasco MA. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer (2011) 11:161-76. doi:10.1038/nrc3025.
39. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature (2009) 460:66-72. doi:10.1038/nature08137.
40. Chung SS, Aroh C, Vadgama JV. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells. PLoS One (2013) 8:e83971. doi:10.1371/journal.pone.0083971.
41. Listerman I, Gazzaniga FS, Blackburn EH. An investigation of the effects of the core protein telomerase reverse transcriptase on wnt signaling in breast cancer cells. Mol Cell Biol (2014) 34:280-9. doi:10.1128/MCB.00844-13.
42. Strong MA, Vidal-Cardenas SL, Karim B, Yu H, Guo N, Greider CW. Phenotypes in mTERT(+)/(-) and mTERT(-)/(-) mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Mol Cell Biol (2011) 31:2369-79. doi:10.1128/MCB.05312-11.
43. Finnon P, Silver AR, Bouffler SD. Upregulation of telomerase activity by X-irradiation in mouse leukaemia cells is independent of Tert, Terc, Tnks and Myc transcription. Carcinogenesis (2000) 21:573-8. doi:10.1093/carcin/21.4.573.
44. Leteurtre F, Li X, Gluckman E, Carosella ED. Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia (1997) 11:1681-9. doi:10.1038/sj.leu.2400784.
45. Neuhof D, Ruess A, Wenz F, Weber KJ. Induction of telomerase activity by irradiation in human lymphoblasts. Radiat Res (2001) 155:693-7. doi:10.1667/0033-7587(2001)155[0693:IOTABI]2.0.CO;2.
46. Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, et al. Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome. Int J Mol Med (1998) 2:301-7.
47. Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, Sukumar S, et al. Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J (1999) 13:1047-54.
48. Terashima M, Ogawa Y, Toda K, Nishioka A, Inomata T, Kubonishi I, et al. Effects of irradiation on telomerase activity in human lymphoma and myeloma cell lines. Int J Mol Med (1998) 2:567-71.
49. Wang X, Liu Y, Chow LS, Wong SC, Tsao GS, Kwong DL, et al. Regulation of telomerase activity by gamma-radiation in nasopharyngeal carcinoma cells. Anticancer Res (2000) 20(1A):433-7.
50. Hyeon Joo O, Hande MP, Lansdorp PM, Natarajan AT. Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res (1998) 401:121-31. doi:10.1016/S0027-5107(97)00321-7.
51. Sridharan DM, Asaithamby A, Bailey SM, Costes SV, Doetsch PW, Dynan WS, et al. Understanding cancer development processes after HZE-particle exposure: roles of ROS, DNA damage repair and inflammation. Radiat Res (2015) 183:1-26. doi:10.1667/RR13804.1.
52. Ayouaz A, Raynaud C, Heride C, Revaud D, Sabatier L. Telomeres: hallmarks of radiosensitivity. Biochimie (2008) 90:60-72. doi:10.1016/j.biochi.2007.09.011.
53. Mirjolet C, Boidot R, Saliques S, Ghiringhelli F, Maingon P, Crehange G. The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy. Cancer Treat Rev (2015) 41:354-60. doi:10.1016/j.ctrv.2015.02.005.
54. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu CM, et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet (2000) 26(1):85-8.
55. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med (2000) 192:1625-36. doi:10.1084/jem.192.11.1625.
56. Berardinelli F, Antoccia A, Buonsante R, Gerardi S, Cherubini R, De Nadal V, et al. The role of telomere length modulation in delayed chromosome instability induced by ionizing radiation in human primary fibroblasts. Environ Mol Mutagen (2013) 54:172-9. doi:10.1002/em.21761.
57. Berardinelli F, Nieri D, Sgura A, Tanzarella C, Antoccia A. Telomere loss, not average telomere length, confers radiosensitivity to TK6-irradiated cells. Mutat Res (2012) 740:13-20. doi:10.1016/j.mrfmmm.2012.11.004.
58. Drissi R, Wu J, Hu Y, Bockhold C, Dome JS. Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells. Cancer Prev Res (Phila) (2011) 4:1973-81. doi:10.1158/1940-6207.CAPR-11-0069.
59. Smirnova A, Gamba R, Khoriauli L, Vitelli V, Nergadze SG, Giulotto E. TERRA expression levels do not correlate with telomere length and radiation sensitivity in human cancer cell lines. Front Oncol (2013) 3:115. doi:10.3389/fonc.2013.00115.
60. Maeda T, Nakamura K, Atsumi K, Hirakawa M, Ueda Y, Makino N. Radiation-associated changes in the length of telomeres in peripheral leukocytes from inpatients with cancer. Int J Radiat Biol (2012) 89(2):106-9. doi:10.3109/09553002.2013.734945.
61. Bailey SM, Meyne J, Chen DJ, Kurimasa A, Li GC, Lehnert BE, et al. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A (1999) 96:14899-904. doi:10.1073/pnas.96.26.14899.
62. Zhang Q, Williams ES, Askin KF, Peng Y, Bedford JS, Liber HL, et al. Suppression of DNA-PK by RNAi has different quantitative effects on telomere dysfunction and mutagenesis in human lymphoblasts treated with gamma rays or HZE particles. Radiat Res (2005) 164:497-504. doi:10.1667/RR3366.1.
63. Zhang Y, Lim CU, Williams ES, Zhou J, Zhang Q, Fox MH, et al. NBS1 knockdown by small interfering RNA increases ionizing radiation mutagenesis and telomere association in human cells. Cancer Res (2005) 65:5544-53. doi:10.1158/0008-5472.CAN-04-4368.
64. Zhang Y, Zhou J, Cao X, Zhang Q, Lim CU, Ullrich RL, et al. Partial deficiency of DNA-PKcs increases ionizing radiation-induced mutagenesis and telomere instability in human cells. Cancer Lett (2007) 250:63-73. doi:10.1016/j.canlet.2006.09.021.
65. Hagelstrom RT, Blagoev KB, Niedernhofer LJ, Goodwin EH, Bailey SM. Hyper telomere recombination accelerates replicative senescence and may promote premature aging. Proc Natl Acad Sci U S A (2010) 107:15768-73. doi:10.1073/pnas.1006338107.
66. Bailey SM, Cornforth MN, Ullrich RL, Goodwin EH. Dysfunctional mammalian telomeres join with DNA double-strand breaks. DNA Repair (2004) 3:349-57. doi:10.1016/j.dnarep.2003.11.007.
67. Williams ES, Klingler R, Ponnaiya B, Hardt T, Schrock E, Lees-Miller SP, et al. Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence. Cancer Res (2009) 69:2100-7. doi:10.1158/0008-5472.CAN-08-2854.
68. Le PN, Maranon DG, Altina NH, Battaglia CL, Bailey SM. TERRA, hnRNP A1, and DNA-PKcs interactions at human telomeres. Front Oncol (2013) 3:91. doi:10.3389/fonc.2013.00091.
69. Levy JA, Virolainen M, Defendi V. Human lymphoblastoid lines from lymph node and spleen. Cancer (1968) 22:517-24. doi:10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A.
70. Bailey SM, Goodwin EH, Cornforth MN. Strand-specific fluorescence in situ hybridization: the CO-FISH family. Cytogenet Genome Res (2004) 107:14-7. doi:10.1159/000079565.
71. Bailey SM, Brenneman MA, Goodwin EH. Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res (2004) 32:3743-51. doi:10.1093/nar/gkh691.
72. Poon SS, Lansdorp PM. Quantitative fluorescence in situ hybridization (Q-FISH). Curr Protoc Cell Biol (2001) 18:14. doi:10.1002/0471143030.cb1804s12.
73. Ourliac-Garnier I, Londono-Vallejo A. Telomere length analysis by quantitative fluorescent in situ hybridization (Q-FISH). Methods Mol Biol (2011) 735:21-31. doi:10.1007/978-1-61779-092-8_3.
74. Dregalla RC, Zhou J, Idate RR, Battaglia CL, Liber HL, Bailey SM. Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs. Aging (2010) 2(10):691-708.
75. Wong HP, Slijepcevic P. Telomere length measurement in mouse chromosomes by a modified Q-FISH method. Cytogenet Genome Res (2004) 105:464-70. doi:10.1159/000078220.
76. Herbert BS, Hochreiter AE, Wright WE, Shay JW. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc (2006) 1:1583-90. doi:10.1038/nprot.2006.239.
77. Hou M, Xu D, Bjorkholm M, Gruber A. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem (2001) 47(3):519-24.
78. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods (2001) 25:402-8. doi:10.1006/meth.2001.1262.
79. Untergrasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3-new capabilities and interfaces. Nucleic Acids Res (2012) 40(15):e115. Available from: http://steverozen.net/; http://bioinfo.ut.ee/primer3/Untergasser_etal_NuclAcidsRes2012.pdf.
80. National Center for Biotechnology Information (NCBI). TERT Telomerase Reverse Transcriptase [Homo sapiens (human)]. Available from: http://www.ncbi.nlm.nih.gov/gene/7015.
81. Seimiya H, Oh-hara T, Suzuki T, Naasani I, Shimazaki T, Tsuchiya K, et al. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol Cancer Ther (2002) 1(9):657-65.
82. Bes S, Tatou E, Vandroux D, Tissier C, Rochette L, Athias P. Physiological and metabolic actions of mycophenolate mofetil on cultured newborn rat cardiomyocytes in normoxia and in simulated ischemia. Fundam Clin Pharmacol (2004) 18:287-98. doi:10.1111/j.1472-8206.2004.00237.x.
83. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 98:1777-85. doi:10.1093/jnci/djj495.
84. Sun H, Jia J, Wang X, Ma B, Di L, Song G, et al. CD44(+)/CD24 (-) breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties. Clin Trans Oncol (2012) 15(1):46-54. doi:10.1007/s12094-012-0891-2.
85. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, et al. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 8:R59. doi:10.1186/bcr1610.
86. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 3:730-7. doi:10.1038/nm0797-730.
87. Williams ES, Stap J, Essers J, Ponnaiya B, Luijsterburg MS, Krawczyk PM, et al. DNA double-strand breaks are not sufficient to initiate recruitment of TRF2. Nat Genet (2007) 39(6):696-8.
88. Liber HL, Idate R, Warner C, Bailey SM. Radiation quality and mutagenesis in human lymphoblastoid cells. Radiat Res (2014) 182:390-5. doi:10.1667/RR13817.1.
89. Bombarde O, Boby C, Gomez D, Frit P, Giraud-Panis MJ, Gilson E, et al. TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends. EMBO J (2010) 29(9):1573-84. doi:10.1038/emboj.2010.49.
90. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature (2007) 448:1068-71. doi:10.1038/nature06065.
91. Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature (2011) 471:532-6. doi:10.1038/nature09772.
92. Hewitt G, Jurk D, Marques FD, Correia-Melo C, Hardy T, Gackowska A, et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun (2012) 3:708. doi:10.1038/ncomms1708.
93. Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol (2012) 14:555. doi:10.1038/ncb0512-555b.
94. Muraki K, Nyhan K, Han L, Murnane JP. Mechanisms of telomere loss and their consequences for chromosome instability. Front Oncol (2012) 2:135. doi:10.3389/fonc.2012.00135.
95. Diehl MC, Idowu MO, Kimmelshue KN, York TP, Jackson-Cook CK, Turner KC, et al. Elevated TRF2 in advanced breast cancers with short telomeres. Breast Cancer Res Treat (2011) 127:623-30. doi:10.1007/s10549-010-0988-7.
96. Tanaka H, Abe S, Huda N, Tu L, Beam MJ, Grimes B, et al. Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A (2012) 109:14098-103. doi:10.1073/pnas.1120062109.
97. Ramsay AJ, Quesada V, Foronda M, Conde L, Martinez-Trillos A, Villamor N, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet (2013) 45(5):526-30. doi:10.1038/ng.2584.
98. Lei H, Zhou FX, Xu H, Peng XH, Zhang ZG, Wang WB, et al. Expression of various protection of telomeres 1 variants is associated with telomere length and radiosensitivity in colon and gastric adenocarcinoma cells. Biomed Rep (2015) 3(3):420-4.
99. Rai R, Zheng H, He H, Luo Y, Multani A, Carpenter PB, et al. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J (2010) 29:2598-610. doi:10.1038/emboj.2010.142.
100. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc-and Wnt-related developmental program. PLoS Genet (2008) 4:e10. doi:10.1371/journal.pgen.0040010.